Abstract:Phospho-tau 217, phospho-tau 231 and phospho-tau 181 in cerebrospinal fluid and plasma are promising biomarkers for the diagnosis of Alzheimer's disease. All these p-tau proteins are detected in neurofibrillary tangles in brains obtained post-mortem from Alzheimer's disease patients. However, increases in p-tau levels in cerebrospinal fluid and plasma during the preclinical stage of Alzheimer's disease correlate with amyloid-β burden and precede neurofibrillary tangles in brains, suggesting that these p-tau proteins are indicative of amyloid-β-mediated brain pathology. In addition, phospho-tau 217 has greater sensitivity than phospho-tau 181, though it is unclear whether each of these p-tau variants contributes to the same or a different type of neuropathology prior to neurofibrillary tangle formation. In this study, we evaluated the intracerebral localization of p-tau in App knock-in mice with amyloid-β plaques without neurofibrillary tangle pathology (AppNLGF ), in App knock-in mice with increased amyloid-β levels without amyloid-β plaques (AppNL ) and in wild-type mice. Immunohistochemical analysis showed that phospho-tau 217 and phospho-tau 231 were detected only in AppNLGF mice as punctate structures around amyloid-β plaques, overlapping with the tau pathology marker, AT8 epitope phospho-tau 202/205/208. Moreover, phospho-tau 217 and phospho-tau 202/205/208 colocalized with the postsynaptic marker PSD95 and with a major tau kinase active, GSK3β. In contrast and similar to total tau, phospho-tau 181 signals were readily detectable as fibre structures in wild-type and AppNL mice and colocalized with an axonal marker neurofilament light chain. In AppNLGF mice, these phospho-tau 181-positive structures were disrupted around amyloid-β plaques and only partially overlapped with phospho-tau 217. These results indicate that phospho-tau 217, phospho-tau 231 and a part of phospho-tau 181 signals are markers of postsynaptic pathology around amyloid-β plaques, with phospho-tau 181 also being a marker of axonal abnormality caused by amyloid-β burden in brains.

Quantitative analysis of P75NTR and hyperphosphorylated tau containing neurons in the hippocampal CA1 subfield of Alzheimer disease

Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tay in Alzheimer patients

Quantitative analysis of CaMKⅡ-α expression and its relationship with hyperphosphorylated tau protein in the hippocampus of Alzheimer disease patients

Quantitative analysis of CaMKⅡ-α expression in the hippocampus of Alzheimer's disease

Increased Apoptotic Neurons in Hippocampus of Alzheimer' S Disease

Quantitative Assessment of Hippocampal Tau Pathology in AD and PART

Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients

Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease

The expression of calcium/calmodulin-dependent protein kinase II-α in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology

Neuropathologic and proteomic analysis of human hippocampal CA1 pyramidal neuron sublayers in human Alzheimer disease

Regional Analysis of Differently Phosphorylated Tau Proteins in Brains from Patients with Alzheimer’s Disease

Decreased coexpression of estrogen receptor -α and -β in the hippocampus of the patient with Alzheimer disease

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Hippocampus Morphometry Study on Pathology-Confirmed Alzheimer's Disease Patients with Surface Multivariate Morphometry Statistics

Changes of Nuclear Factor and Inflammatory Chemotactic Factors in Brain of Patients with Alzheimer's Disease

Distinct brain pathologies associated with Alzheimer's disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis

The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer's Disease Pathology

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Associations of the A/T/N Profiles in PET, CSF, and Plasma Biomarkers with Alzheimer's Disease Neuropathology at Autopsy.

Study on Apoptosis of Neurons in Rat Hippocampus and Expression of Related Proteins in Path of Mitochondrion after Injection of Aβ,1-42

Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer's disease.